QQQ   444.26 (-0.13%)
AAPL   171.22 (-1.21%)
MSFT   419.90 (-0.36%)
META   485.80 (-1.63%)
GOOGL   150.63 (-0.16%)
AMZN   180.13 (+0.17%)
TSLA   177.49 (-1.30%)
NVDA   905.75 (+0.36%)
NIO   4.58 (-1.93%)
AMD   181.20 (+0.90%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   9.90 (+3.66%)
GE   175.20 (-2.73%)
DIS   122.59 (+1.33%)
AMC   3.67 (-15.44%)
PFE   27.99 (+0.76%)
PYPL   67.23 (+0.99%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.22 (-1.21%)
MSFT   419.90 (-0.36%)
META   485.80 (-1.63%)
GOOGL   150.63 (-0.16%)
AMZN   180.13 (+0.17%)
TSLA   177.49 (-1.30%)
NVDA   905.75 (+0.36%)
NIO   4.58 (-1.93%)
AMD   181.20 (+0.90%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   9.90 (+3.66%)
GE   175.20 (-2.73%)
DIS   122.59 (+1.33%)
AMC   3.67 (-15.44%)
PFE   27.99 (+0.76%)
PYPL   67.23 (+0.99%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.22 (-1.21%)
MSFT   419.90 (-0.36%)
META   485.80 (-1.63%)
GOOGL   150.63 (-0.16%)
AMZN   180.13 (+0.17%)
TSLA   177.49 (-1.30%)
NVDA   905.75 (+0.36%)
NIO   4.58 (-1.93%)
AMD   181.20 (+0.90%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   9.90 (+3.66%)
GE   175.20 (-2.73%)
DIS   122.59 (+1.33%)
AMC   3.67 (-15.44%)
PFE   27.99 (+0.76%)
PYPL   67.23 (+0.99%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.22 (-1.21%)
MSFT   419.90 (-0.36%)
META   485.80 (-1.63%)
GOOGL   150.63 (-0.16%)
AMZN   180.13 (+0.17%)
TSLA   177.49 (-1.30%)
NVDA   905.75 (+0.36%)
NIO   4.58 (-1.93%)
AMD   181.20 (+0.90%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   9.90 (+3.66%)
GE   175.20 (-2.73%)
DIS   122.59 (+1.33%)
AMC   3.67 (-15.44%)
PFE   27.99 (+0.76%)
PYPL   67.23 (+0.99%)
XOM   115.69 (+0.63%)
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

$15.19
+0.55 (+3.76%)
(As of 12:53 PM ET)
Today's Range
$14.66
$15.79
50-Day Range
$5.77
$20.25
52-Week Range
$2.60
$20.52
Volume
1.05 million shs
Average Volume
1.64 million shs
Market Capitalization
$670.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.20

Cardlytics MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
14.2% Downside
$13.20 Price Target
Short Interest
Bearish
10.16% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.37mentions of Cardlytics in the last 14 days
Based on 12 Articles This Week
Insider Trading
Acquiring Shares
$8.96 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.99 out of 5 stars

Business Services Sector

191st out of 311 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

35th out of 56 stocks

CDLX stock logo

About Cardlytics Stock (NASDAQ:CDLX)

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CDLX Stock Price History

CDLX Stock News Headlines

Why Cardlytics (CDLX) Stock Is Down 30%
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Why Cardlytics Stock Tanked by 33% Today
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Cardlytics (NASDAQ:CDLX) Shares Gap Up to $15.24
CDLX May 2024 12.500 call
CDLX Jul 2024 17.500 put
Cardlytics Inc.
See More Headlines
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2021
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:CDLX
Fax
N/A
Employees
473
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$13.20
High Stock Price Target
$18.00
Low Stock Price Target
$6.00
Potential Upside/Downside
-13.1%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-134,700,000.00
Pretax Margin
-43.56%

Debt

Sales & Book Value

Annual Sales
$309.20 million
Cash Flow
$1.40 per share
Book Value
$3.43 per share

Miscellaneous

Free Float
43,765,000
Market Cap
$670.03 million
Optionable
Optionable
Beta
1.36

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Karim Temsamani (Age 50)
    CEO & Director
    Comp: $424.02k
  • Mr. Nick Lynton
    Chief Legal & Privacy Officer and Secretary
  • Ms. Alexis DeSieno
    Chief Financial Officer
  • Mr. Amit Gupta
    COO & GM of Bridg
  • Mr. Peter Chan
    Chief Technology Officer
  • Mr. Peter Davies
    Head of Sales Strategy & Operations
  • Ms. Carson Napps
    Head of People
  • Mr. Jose Singer
    Chief Product Officer
  • Ms. Evelyne Forester
    Chief Business Officer

CDLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardlytics stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CDLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDLX, but not buy additional shares or sell existing shares.
View CDLX analyst ratings
or view top-rated stocks.

What is Cardlytics' stock price target for 2024?

5 brokerages have issued 12 month target prices for Cardlytics' shares. Their CDLX share price targets range from $6.00 to $18.00. On average, they expect the company's share price to reach $13.20 in the next year. This suggests that the stock has a possible downside of 14.2%.
View analysts price targets for CDLX
or view top-rated stocks among Wall Street analysts.

How have CDLX shares performed in 2024?

Cardlytics' stock was trading at $9.21 at the beginning of 2024. Since then, CDLX stock has increased by 67.0% and is now trading at $15.38.
View the best growth stocks for 2024 here
.

When is Cardlytics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CDLX earnings forecast
.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) announced its quarterly earnings results on Tuesday, May, 4th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.22. The firm earned $53 million during the quarter, compared to analyst estimates of $51.96 million. Cardlytics had a negative trailing twelve-month return on equity of 25.38% and a negative net margin of 43.56%. The business's quarterly revenue was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.26) earnings per share.
Read the conference call transcript
.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million.

What is Lynne Laube's approval rating as Cardlytics' CEO?

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.49%), Vanguard Group Inc. (5.49%), Worldly Partners Management LLC (2.95%), Baillie Gifford & Co. (2.41%), Dimensional Fund Advisors LP (1.90%) and General Equity Holdings LP (1.59%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes.
View institutional ownership trends
.

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cardlytics have any subsidiaries?
The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.
Read More
This page (NASDAQ:CDLX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners